Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (335)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
29
2025
187
13.150
 Why?
Anticonvulsants
20
2025
134
9.050
 Why?
Seizures
24
2025
208
6.260
 Why?
Tuberous Sclerosis
8
2025
39
4.370
 Why?
Spasms, Infantile
11
2025
30
4.250
 Why?
Cannabidiol
8
2025
43
4.040
 Why?
Status Epilepticus
6
2021
36
3.350
 Why?
Epilepsies, Myoclonic
5
2024
14
3.110
 Why?
Mutation
16
2023
1347
3.040
 Why?
Deep Brain Stimulation
4
2025
43
2.850
 Why?
Humans
117
2025
52483
2.670
 Why?
Electroencephalography
18
2024
312
2.500
 Why?
Intellectual Disability
5
2023
127
2.200
 Why?
Child
42
2025
7248
2.190
 Why?
Brain
10
2024
1323
2.120
 Why?
Hemiplegia
3
2021
12
2.020
 Why?
Developmental Disabilities
5
2019
122
1.690
 Why?
Epilepsy, Absence
3
2019
11
1.650
 Why?
Magnetic Resonance Imaging
16
2025
1546
1.610
 Why?
Infant
24
2025
3733
1.570
 Why?
Genetic Therapy
2
2025
121
1.500
 Why?
Tumor Suppressor Proteins
3
2023
130
1.400
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.400
 Why?
Algorithms
2
2025
672
1.400
 Why?
Nervous System Malformations
3
2020
16
1.390
 Why?
Folate Receptor 1
2
2022
27
1.360
 Why?
Child, Preschool
22
2025
4076
1.310
 Why?
Infant, Newborn, Diseases
2
2020
56
1.280
 Why?
Epilepsies, Partial
2
2022
14
1.280
 Why?
Ketamine
2
2020
59
1.270
 Why?
Vagus Nerve Stimulation
2
2025
14
1.170
 Why?
Neurocutaneous Syndromes
2
2019
6
1.150
 Why?
Cadherins
2
2019
62
1.130
 Why?
Cerebral Arteries
2
2019
30
1.060
 Why?
Epilepsy, Generalized
2
2023
9
1.040
 Why?
Vigabatrin
3
2024
3
1.030
 Why?
Sirolimus
2
2017
65
1.020
 Why?
Angiofibroma
2
2015
5
0.990
 Why?
Facial Neoplasms
2
2015
22
0.970
 Why?
Nerve Tissue Proteins
2
2018
187
0.960
 Why?
Male
37
2025
26761
0.960
 Why?
Treatment Outcome
13
2025
5422
0.950
 Why?
Valproic Acid
2
2022
35
0.950
 Why?
Neurosurgical Procedures
2
2025
135
0.940
 Why?
Female
33
2025
28171
0.930
 Why?
Fenfluramine
2
2024
8
0.910
 Why?
Stroke
3
2019
512
0.900
 Why?
Dioxolanes
2
2024
15
0.890
 Why?
Randomized Controlled Trials as Topic
2
2024
595
0.890
 Why?
Thalamus
1
2024
35
0.890
 Why?
Pregnanolone
2
2023
6
0.870
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.810
 Why?
Quality Improvement
2
2022
226
0.780
 Why?
Aphasia
1
2022
33
0.780
 Why?
Nervous System Diseases
2
2021
95
0.750
 Why?
Chromosome Deletion
3
2019
142
0.750
 Why?
Abnormalities, Multiple
3
2023
166
0.740
 Why?
Emergencies
1
2021
81
0.710
 Why?
Pharmaceutical Preparations
1
2021
77
0.710
 Why?
Angelman Syndrome
1
2020
1
0.700
 Why?
Transition to Adult Care
1
2020
18
0.690
 Why?
Bone Diseases, Developmental
2
2023
17
0.680
 Why?
Tooth Abnormalities
2
2023
13
0.680
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.670
 Why?
Adolescent
15
2025
6739
0.670
 Why?
Oligonucleotides, Antisense
1
2020
30
0.660
 Why?
Phenobarbital
1
2020
17
0.660
 Why?
Flunarizine
1
2019
1
0.660
 Why?
Behavioral Symptoms
1
2019
4
0.660
 Why?
Immunologic Factors
1
2021
117
0.660
 Why?
Excitatory Amino Acid Antagonists
1
2020
46
0.650
 Why?
Ocular Physiological Phenomena
1
2019
3
0.650
 Why?
Tetrasomy
1
2019
2
0.640
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.640
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.640
 Why?
Sneddon Syndrome
1
2019
3
0.640
 Why?
Livedo Reticularis
1
2019
5
0.640
 Why?
Oral Ulcer
1
2019
3
0.630
 Why?
Calcium Channel Blockers
1
2019
60
0.630
 Why?
Behcet Syndrome
1
2019
7
0.630
 Why?
Transposases
1
2019
10
0.630
 Why?
Andersen Syndrome
1
2019
1
0.620
 Why?
Spinal Cord Diseases
1
2019
39
0.620
 Why?
Hydrocephalus
1
2019
43
0.620
 Why?
Receptors, GABA-B
1
2019
12
0.620
 Why?
Vitiligo
1
2019
8
0.620
 Why?
Leukoencephalopathies
1
2019
14
0.620
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.620
 Why?
Nephrotic Syndrome
2
2017
19
0.610
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.610
 Why?
Migraine Disorders
2
2020
47
0.610
 Why?
Edema
1
2019
66
0.610
 Why?
Cerebral Infarction
1
2018
34
0.610
 Why?
Electron Transport Complex IV
1
2018
24
0.610
 Why?
Muscle Weakness
1
2019
45
0.600
 Why?
Cannabinoid Receptor Agonists
1
2019
51
0.600
 Why?
Optic Atrophy
1
2018
16
0.600
 Why?
Physicians
1
2022
241
0.600
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.600
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.600
 Why?
Photic Stimulation
1
2018
56
0.600
 Why?
Shab Potassium Channels
1
2018
2
0.600
 Why?
Alopecia
1
2019
38
0.600
 Why?
Brain Edema
1
2018
36
0.590
 Why?
Parents
1
2021
335
0.580
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.580
 Why?
Thrombocytopenia
1
2019
89
0.580
 Why?
Myoclonus
1
2018
9
0.580
 Why?
Artifacts
1
2018
55
0.580
 Why?
Autoimmune Diseases
1
2019
86
0.570
 Why?
Biomedical Research
1
2021
256
0.570
 Why?
Mitochondrial Diseases
1
2018
45
0.570
 Why?
Neurodegenerative Diseases
1
2018
80
0.560
 Why?
Practice Guidelines as Topic
1
2020
488
0.560
 Why?
Hearing Loss, Sensorineural
1
2018
79
0.540
 Why?
Osteochondrodysplasias
1
2017
14
0.540
 Why?
Immunologic Deficiency Syndromes
1
2017
18
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
509
0.540
 Why?
Models, Biological
1
2020
735
0.540
 Why?
Arteriosclerosis
1
2017
53
0.540
 Why?
Carotid Artery Diseases
1
2017
31
0.540
 Why?
Phenotype
2
2021
789
0.530
 Why?
Infant, Newborn
6
2024
2867
0.530
 Why?
Drug Discovery
1
2017
93
0.530
 Why?
Child Development
1
2018
200
0.520
 Why?
Prenatal Exposure Delayed Effects
1
2018
197
0.520
 Why?
Cafe-au-Lait Spots
1
2016
2
0.510
 Why?
Williams Syndrome
1
2016
25
0.500
 Why?
Erythema Infectiosum
1
2015
3
0.500
 Why?
Corpus Callosum
2
2023
27
0.500
 Why?
Migraine with Aura
1
2015
5
0.500
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.500
 Why?
Skin
1
2019
422
0.500
 Why?
Sinus Pericranii
1
2015
1
0.500
 Why?
Pulmonary Embolism
1
2017
86
0.500
 Why?
Syndrome
6
2024
247
0.500
 Why?
Parvovirus B19, Human
1
2015
17
0.500
 Why?
Toes
1
2015
15
0.500
 Why?
Electrodiagnosis
1
2015
13
0.490
 Why?
SOS1 Protein
1
2015
2
0.490
 Why?
Crying
1
2015
4
0.490
 Why?
Moyamoya Disease
1
2015
7
0.490
 Why?
Iatrogenic Disease
1
2015
24
0.490
 Why?
Hyperventilation
1
2015
8
0.490
 Why?
Tuberculoma
1
2015
1
0.490
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.490
 Why?
Noonan Syndrome
1
2015
12
0.490
 Why?
Neurologic Examination
1
2015
73
0.480
 Why?
Encephalitis
1
2016
39
0.480
 Why?
Ocular Motility Disorders
1
2015
17
0.480
 Why?
Mutism
1
2015
3
0.480
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.480
 Why?
Communication
3
2022
257
0.480
 Why?
TOR Serine-Threonine Kinases
1
2015
80
0.470
 Why?
Repressor Proteins
2
2023
155
0.470
 Why?
Diagnosis, Differential
7
2020
1046
0.470
 Why?
Trisomy
1
2014
35
0.460
 Why?
Neurology
1
2015
35
0.460
 Why?
Influenza, Human
1
2015
93
0.450
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.450
 Why?
Energy Drinks
1
2014
6
0.450
 Why?
Vasoconstriction
1
2014
55
0.450
 Why?
Benzodiazepines
1
2014
71
0.440
 Why?
Osteomyelitis
1
2015
125
0.430
 Why?
Membrane Proteins
1
2016
335
0.430
 Why?
Sleep
1
2014
187
0.420
 Why?
Enzyme Inhibitors
1
2015
372
0.410
 Why?
Quality of Life
4
2025
879
0.400
 Why?
Magnetic Resonance Angiography
3
2019
67
0.400
 Why?
Immunosuppressive Agents
3
2019
243
0.380
 Why?
Consensus
2
2025
181
0.380
 Why?
Pediatrics
1
2015
293
0.370
 Why?
Retrospective Studies
8
2025
6607
0.370
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
79
0.350
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
133
0.340
 Why?
Clinical Trials as Topic
2
2024
467
0.330
 Why?
Caregivers
2
2021
240
0.310
 Why?
Recurrence
3
2019
672
0.310
 Why?
Echinocandins
1
2008
64
0.300
 Why?
Mycoses
1
2008
152
0.280
 Why?
Gastroesophageal Reflux
2
2019
48
0.270
 Why?
Antifungal Agents
1
2008
347
0.250
 Why?
Administration, Topical
2
2015
61
0.250
 Why?
Adult
6
2025
14161
0.240
 Why?
Seizures, Febrile
1
2024
2
0.230
 Why?
Meta-Analysis as Topic
1
2024
40
0.230
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
 Why?
Psychosurgery
1
2023
5
0.220
 Why?
Databases, Factual
2
2024
706
0.220
 Why?
Laser Therapy
1
2023
82
0.200
 Why?
Speech Disorders
1
2022
16
0.200
 Why?
Ethosuximide
1
2022
5
0.200
 Why?
Clonazepam
1
2022
6
0.200
 Why?
Electrodes, Implanted
1
2022
32
0.200
 Why?
Cluster Analysis
1
2023
233
0.200
 Why?
Stereotaxic Techniques
1
2022
40
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
25
0.190
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Palliative Care
1
2024
214
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
 Why?
Freedom
1
2021
3
0.190
 Why?
Diazepam
1
2021
17
0.190
 Why?
Folic Acid
1
2022
140
0.190
 Why?
Drug Interactions
1
2022
206
0.180
 Why?
Fibroma
1
2021
40
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
30
0.180
 Why?
Personal Satisfaction
1
2021
75
0.180
 Why?
Soft Tissue Neoplasms
1
2021
57
0.180
 Why?
Risk Factors
2
2020
3889
0.180
 Why?
Dihydroergotamine
1
2020
5
0.170
 Why?
Brain Diseases
1
2021
79
0.170
 Why?
Perception
1
2021
120
0.170
 Why?
Transcription Factors
2
2023
566
0.170
 Why?
Mental Disorders
1
2025
428
0.170
 Why?
Facies
2
2023
36
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
24
0.170
 Why?
Clinical Protocols
1
2020
108
0.170
 Why?
Treatment Failure
1
2020
122
0.160
 Why?
Anesthetics
1
2020
36
0.160
 Why?
Ubiquitin-Protein Ligases
1
2020
96
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Muscle Hypotonia
1
2019
23
0.160
 Why?
Learning
1
2021
160
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
30
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
 Why?
Qualitative Research
1
2021
364
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
29
0.160
 Why?
Patient-Centered Care
1
2021
141
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
 Why?
Ventricular Premature Complexes
1
2019
6
0.160
 Why?
Disease Management
1
2020
188
0.160
 Why?
Microcephaly
1
2019
41
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Referral and Consultation
1
2021
292
0.150
 Why?
Syncope
1
2019
30
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
17
0.150
 Why?
Facial Paralysis
1
2018
25
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.150
 Why?
Health Personnel
1
2021
256
0.150
 Why?
Acute Disease
1
2019
373
0.150
 Why?
Deglutition Disorders
1
2019
79
0.150
 Why?
Fatal Outcome
1
2019
197
0.150
 Why?
Video Recording
1
2018
81
0.150
 Why?
Fibrinolytic Agents
1
2019
128
0.150
 Why?
Frameshift Mutation
1
2018
18
0.150
 Why?
Combined Modality Therapy
1
2020
639
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
82
0.140
 Why?
India
1
2017
68
0.140
 Why?
Cerebellum
1
2018
125
0.140
 Why?
Platelet Aggregation Inhibitors
1
2019
181
0.140
 Why?
History, 21st Century
1
2017
59
0.140
 Why?
History, 20th Century
1
2017
96
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
77
0.140
 Why?
Pandemics
1
2021
585
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
91
0.130
 Why?
Anti-Infective Agents
1
2017
107
0.130
 Why?
Animals
3
2022
13505
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
 Why?
Hormones
1
2016
59
0.130
 Why?
Influenza B virus
1
2015
6
0.130
 Why?
Delayed Diagnosis
1
2016
30
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
19
0.120
 Why?
Arkansas
1
2021
2028
0.120
 Why?
North America
1
2015
73
0.120
 Why?
Cerebral Angiography
1
2015
87
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
80
0.120
 Why?
Complementary Therapies
1
2015
25
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.120
 Why?
Brain Waves
1
2014
19
0.120
 Why?
Drug Resistance
1
2015
65
0.120
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
461
0.110
 Why?
Headache
1
2014
76
0.110
 Why?
Vomiting
1
2014
73
0.110
 Why?
Mutation, Missense
1
2014
108
0.110
 Why?
Glutamine
1
2015
176
0.110
 Why?
Arginine
1
2015
182
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.100
 Why?
Analgesics
1
2014
107
0.100
 Why?
Diagnostic Errors
1
2013
68
0.100
 Why?
Evidence-Based Medicine
1
2013
261
0.090
 Why?
Inflammation
1
2016
641
0.090
 Why?
Pregnancy
1
2018
2680
0.090
 Why?
Signal Transduction
1
2017
1671
0.090
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Antineoplastic Agents
1
2017
1222
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
44
0.070
 Why?
Lipopeptides
1
2008
62
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
152
0.070
 Why?
Candidiasis
1
2008
113
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
85
0.070
 Why?
Kidney Diseases
1
2009
220
0.070
 Why?
Prospective Studies
2
2023
2481
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
 Why?
Observer Variation
1
2024
134
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
483
0.050
 Why?
Probability
1
2023
172
0.050
 Why?
Neuroimaging
1
2023
94
0.050
 Why?
Young Adult
2
2025
4329
0.050
 Why?
Potassium Channels
1
2021
32
0.050
 Why?
Registries
1
2024
581
0.040
 Why?
Reproducibility of Results
1
2024
1229
0.040
 Why?
Administration, Intravenous
1
2020
73
0.040
 Why?
Sleep Stages
1
2020
40
0.040
 Why?
Age of Onset
1
2020
110
0.040
 Why?
Cognition
1
2022
331
0.040
 Why?
Follow-Up Studies
1
2025
2279
0.040
 Why?
Immunohistochemistry
1
2021
979
0.040
 Why?
Aged
1
2025
10121
0.020
 Why?
Software
1
2013
280
0.020
 Why?
Internet
1
2013
263
0.020
 Why?
Middle Aged
1
2025
13028
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
107
0.020
 Why?
Colonoscopy
1
2009
108
0.020
 Why?
Prognosis
1
2009
2099
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (335) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department